Skip to main content
. 2019 Jan 28;69(11):1888–1895. doi: 10.1093/cid/ciz063

Figure 1.

Figure 1.

Impact of HCV chronic prevalence among pregnant women (x-axis) on the ICER (y-axis) of universal screening pregnant woman, compared to background risk-based screening. The willingness to pay a threshold of $50 000/QALY is denoted by a horizontal, dashed line. Abbreviations: F0, fibrosis stage 0; HCV, hepatitis C virus; ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life-years; USD, US dollars.